New research outlines promising therapies for small cell lung cancer

Researchers from University Hospitals Seidman Cancer Center publish new findings

2014-09-25

(Press-News.org) CLEVELAND: Two recently published studies by a research team at University Hospitals (UH) Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and "is a disease in urgent need of new drug therapies," write the study's authors.

"In small cell lung cancer, which impacts about 30-40,000 people each year in the United States, there has been no therapeutic progress and very little research," says Afshin Dowlati, MD, lead author and Director of the Center for Cancer Drug Development at UH Seidman Cancer Center. "Additionally, there are no approved targeted therapies for the disease. These studies lay the foundation for future research aimed at finding important new treatments for this highly malignant cancer."

A study titled, RET Mutation and Expression in Small Cell Lung Cancer, was published in the September issue of Journal of Thoracic Oncology and found a new mutation in SCLC which may play a role in the disease's development. The researchers found that the genetic mutation, called RET (rearranged during transfection), was linked to rapid cell growth.

The research team examined specimens in its database of metastatic SCLC tumors, one of the largest databases of its kind in the country. They found that the RET mutant protein was potentially linked to faster-growing cells that were sensitive to ponatinib and vandetanib, two new targeted drug therapies. Future clinical trials for patients with the RET mutation are planned to further validate the data.

"We were encouraged to find that these two cancer-fighting therapies are potentially effective at stopping cancer cell growth in certain small cell lung cancers," says Dr. Dowlati, who is Professor of Medicine – Hematology/Oncology, Case Western Reserve University School of Medicine and a member of the Case Comprehensive Cancer Center. "These findings have the potential to give cancer physicians a new tool to more effectively tailor treatments for patients."

The other study, published in PLOS One, outlines a novel approach to identify new drug therapies for SCLC based on tumors' genomic profiles. The research team discovered new molecular targets for treating the disease by extracting data from SCLC tumors to examine drug sensitivity. Through this analysis, they outlined a promising new approach to predict which cancer-fighting drugs would be the most broadly effective at slowing tumor growth. "This study enabled us to identify which drugs may be the most useful in which types of tumors," says Dr. Dowlati. "Small cell lung cancer is one of the fastest growing cancers and these studies have yielded small but important therapeutic insights into this disease." Dr. Dowlati is additionally the Rosalie and Morton A. Cohen Chair in Oncology and the Lucile and Robert H. Gries Endowed Director, Center for Cancer Drug Development at UH Seidman Cancer Center.

INFORMATION: Both studies were funded by the UH Seidman Cancer Center, part of the Case Comprehensive Cancer Center at Case Western Reserve.

About University Hospitals University Hospitals, the second largest employer in Northeast Ohio with 25,000 employees, serves the needs of patients through an integrated network of 15 hospitals, 28 outpatient health centers and primary care physician offices in 15 counties. At the core of our $3.5 billion health system is University Hospitals Case Medical Center, ranked among America's 50 best hospitals by U.S. News & World Report in all 12 methodology-ranked specialties. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation, including cancer, pediatrics, women's health, orthopaedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. For more information, go to http://www.uhhospitals.org

ELSE PRESS RELEASES FROM THIS DATE:

Coping techniques help patients with COPD improve mentally, physically

2014-09-25

DURHAM, N.C. -- Coaching patients with chronic obstructive pulmonary disease to manage stress, practice relaxation and participate in light exercise can boost a patient's quality of life and can even improve physical symptoms, researchers at Duke Medicine report. In a study published online Sept. 25, 2014, in the journal Psychosomatic Medicine, Duke researchers examined how telephone-based coaching could help patients with chronic obstructive pulmonary disease, or COPD, a progressive disease that limits airflow in the lungs. About 15 million Americans have COPD, and ...

Solar cell compound probed under pressure

2014-09-25

Washington, D.C.— Gallium arsenide, GaAs, a semiconductor composed of gallium and arsenic is well known to have physical properties that promise practical applications. In the form of nanowires and nanoparticles, it has particular potential for use in the manufacture of solar cells and optoelectronics in many of the same applications that silicon is commonly used. But the natural semiconducting ability of GaAs requires some tuning in order to make it more desirable for use in manufacturing these types of products. New work from a team led by Carnegie's Alexander Goncharov ...

A wriggly solution to a first-world problem

2014-09-25

Australian researchers have achieved groundbreaking results in a clinical trial using hookworms to reduce the symptoms of celiac disease. The results are also good news for sufferers of other inflammatory conditions such as asthma and Crohn's disease. In the small trial run over a year, 12 participants were each experimentally infected with 20 Necator americanus (hookworm) larvae. They were then given gradually increasing doses of gluten – beginning with just one-tenth of a gram per day (the equivalent of less than a one-inch segment of spaghetti) and increasing in ...

Study finds global sea levels rose up to 5 meters per century at the end of the last 5 ice ages

2014-09-25

Land-ice decay at the end of the last five ice-ages caused global sea-levels to rise at rates of up to 5.5 metres per century, according to a new study. An international team of researchers developed a 500,000-year record of sea-level variability, to provide the first account of how quickly sea-level changed during the last five ice-age cycles. The results, published in the latest issue of Nature Communications, also found that more than 100 smaller events of sea-level rise took place in between the five major events. Dr Katharine Grant, from the Australian National ...

Cryptogenic strokes may find explanation in the heart

2014-09-25

More than half of the patients who have suffered a stroke with no well-defined aetiology have an enlarged left atrial appendage of the heart, according to a Finnish study. The results indicate that the enlargement of the left atrial appendage may be an independent risk factor of strokes with cardiac origin. Mr Mikko Taina, Licentiate of Medicine, presented the results in his doctoral thesis at the University of Eastern Finland. Stroke is the leading cause of long-term disability and a major burden on health-care resources worldwide. Stroke is responsible for 10 per ...

Osteoarthritis of the hip: Appropriate exercise therapy can alleviate symptoms

2014-09-25

Osteoarthritis of the hip is a progressive degenerative disorder affecting the hip joints, which affects one in 10 adults. The symptoms range from pain after intense joint loading to morning pain/stiffness and impaired mobility in everyday life. To date, no cure exists. Appropriate exercise therapy can, however, delay progression of the disease and alleviate symptoms, as shown in a randomized controlled study reported by Inga Krauß et al in Deutsches Ärzteblatt (Dtsch Arztebl Int 2014; 111: 592–9). The physicians treated patients with hip osteoarthritis according to the ...

Human papilloma virus vaccination provides long-term protection

2014-09-25

Every year, 11.2 of every 100 000 women in Germany develop cervical cancer. Persistent infection with a high-risk human papillomavirus (HPV) type is a necessary prerequisite for the development of dysplasia and neoplasia of the cervix. HPV vaccination has been a subject of heated debate since it was incorporated into the vaccination recommendations of the German Standing Committee on Vaccination (STIKO) in 2007. This edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2014; 111: 584–91) reveals that Yvonne Deleré of Berlin's Robert Koch Institute et al. have ...

Brains not recognizing an angry expression

2014-09-25

Inattention, hyperactivity, and impulsive behavior in children with ADHD can result in social problems and they tend to be excluded from peer activities. They have been found to have impaired recognition of emotional expression from other faces. The research group of Professor Ryusuke Kakigi of the National Institute for Physiological Sciences, National Institutes of Natural Sciences, in collaboration with Professor Masami K. Yamaguchi and Assistant Professor Hiroko Ichikawa of Chuo University first identified the characteristics of facial expression recognition of children ...

Chemists recruit anthrax to deliver cancer drugs

2014-09-25

CAMBRIDGE, MA -- Bacillus anthracis bacteria have very efficient machinery for injecting toxic proteins into cells, leading to the potentially deadly infection known as anthrax. A team of MIT researchers has now hijacked that delivery system for a different purpose: administering cancer drugs. "Anthrax toxin is a professional at delivering large enzymes into cells," says Bradley Pentelute, the Pfizer-Laubauch Career Development Assistant Professor of Chemistry at MIT. "We wondered if we could render anthrax toxin nontoxic, and use it as a platform to deliver antibody ...

Scientists develop tool to help communities stay environmentally and socially 'healthy'

2014-09-25

Geographers at the University of Southampton have developed a new way to measure the 'health' of poor regional communities. They aim to improve the wellbeing of people by guiding sustainable development practices to help avoid social and environmental collapse. The researchers have pioneered a methodology that examines the balance between factors such as; standards of living, natural resources, agriculture, industry and the economy. The results help identify critical limits, beyond which regions risk tipping into ecological and social downturn, or even collapse. The ...

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

New research outlines promising therapies for small cell lung cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: